{"name":"Scioto Biosciences, Inc.","slug":"scioto-biosciences-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi1wJBVV95cUxQMnRjM0FlUlpnYmpKNWtfRTJHUkc4X3poQW5CZUo5VkRxOTU1bktlQ1dIQmxYamFldDBWS2FmekhqeW91dVYtMWJfT1NpbXhYV2UzWlFibWpIWGpSdzFVelJXSFZZbDVuMjlMZVltelA0Q0ZoSmtQOXVDbUxKZTNfYUNNemhlVE5zTlhRcGo3NVFLVnNzMkNYUFpmN1lVSzZiUE00Tk10WW1ab2pfamFMTlBlTTluNGVtYzl4TVdwSGhZSU41Z2xaQU1nbGUxQVE2TGNYQnBKRXpxbkVRTWJMR29MRjR4aUdmQnp3REJzS0kyU3ZBUVZEWWVUQnAwRnNtX0drQVpQY3RqS2VzUnM1UkxhcUZubXJiWDFEYzNQNmZiWGVzb0dqakNxTVlCeXgtTTFzYV96UGNxblpvdDEwNHpsYVZPZWdLQzV2bVd6cVdUVEV4WFhB?oc=5","date":"2026-04-06","type":"regulatory","source":"Barchart.com","summary":"Autistic Disorder Pipeline 2026: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveInsight | Jazz Pharma, Axial Therapeutics, Eli Lilly and Company, Scioto Bioscienc","headline":"Autistic Disorder Pipeline 2026: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveIn","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMi3wFBVV95cUxQUUp0ZDNaUzVYRlFqY0ZEaUtCOGFlSjg4ZmpYLWVCd3RVMG4yR1dZZVlLRmRjb0dDb2s1eXJvU01BMWpuZmlZZENrbUFVbUJseGp5QVA0dG9TYVo3WFAyQ2Zuc3ZXVlRwdnVlVWF5VTNaXzdtVTV3QlowUWc1OG1jd1lhWGczWEg2c2RLTDVKbUpDbl9xajVLeE1HUmtxVGgxWTkyQVpXaUVtR3BPWnozUjZzVjdad085bnFGNnE2clhlbGFVV2V5V0w1YXd1UGdXcm1YWG1GeUNwTEoyWC1R?oc=5","date":"2025-10-20","type":"pipeline","source":"PR Newswire","summary":"Plug and Play Lifetech Announces Inaugural Batch of 12 Innovative Startups in Indianapolis - PR Newswire","headline":"Plug and Play Lifetech Announces Inaugural Batch of 12 Innovative Startups in Indianapolis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgJBVV95cUxOZFFXbjY5X19SVW9xSlRDdjdlUkgzYnRNbnFFRzU5WjBwUXpyS2xYRm5Sd2sxWndTZ3RpOHFiNEJjbU1CXzg1M3hwSkN5TW1tY05TZG5BMmtGNmZNS1F5WGRxR3F5MzhqSnRzWndvaS0zMGgxQWdfU2VwU1V2ckZxYVVEOGxDRlMzTEVsZm5yU045QWhLWURlTXdRcFhXSXZTb0h0WjVBMklWTTNLVG5hdm04MG1hWUJXUEdUSFlnZHNPT2VuNlFkNXEtVGNXc1FPang4Q09JOVVKMjNTYjB2ZHd3QlVlUC13ZkR2RG5OV0llZ3hicUg5SjdPc1lieXE4eUR0X2lnRTY0SUlDTzRPV1dpQU1tMWRDYjZGTGh1enZpS1RJa2w1SWRtbWF4dw?oc=5","date":"2025-06-26","type":"trial","source":"GlobeNewswire","summary":"Autism Spectrum Disorder Clinical Trial Analysis: Key - GlobeNewswire","headline":"Autism Spectrum Disorder Clinical Trial Analysis: Key","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixgJBVV95cUxOYUJKaG5ZZk4xakNndFIxZlI4dTJ5aUp4UkUxZEp3TFFxdFVPSmNibUhVR25TRGFfSDBPd1ZVRzRsb3JFTUVaVWxiMHlyNWhFS2dyeG5STm5GdFpZR0cyb0l4T0RWYzJGbnYzMjEwd0t4ZElJVTN3aGhIUzh5dzFlQ1pNRWhPV2FSYlE4NVpSczFHX2JYaEJUYi10aFJRWEZyS0ZTUjZSZUtTSDhvT3NURmlqcmY2bVNiWnFON0ZQTkwzOWs4SmRXbGZKWGZHaERuUU1HRXpaQUUyY0xRRThUQkkyaGNlT01DZVlHb3JxT1JTbzhfSGJTM2NCUWVObWlScm15R2VtQ2FjVHN3LXpydG5qZF9iUWFoeXExa21rN0djcVRhSGZVNGtqa1hkMV9NdUlJMzJoRjV1dS1TMi1pbk5FY0RnQQ?oc=5","date":"2024-07-04","type":"pipeline","source":"PR Newswire","summary":"Autism Spectrum Disorder Therapeutics Market size is set to grow by USD 766.1 million from 2024-2028, Increasing prevalence of asd to boost the market growth, Technavio - PR Newswire","headline":"Autism Spectrum Disorder Therapeutics Market size is set to grow by USD 766.1 million from 2024-2028, Increasing prevale","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE5hYV9va3dWS1BrNlZ5UEtzT043aXZGWENaSXNqYTI4VDBpdXVCTEJING9WTHNaSjhHRElhOVNDWWI2WnVEN1A5NW9XT1RvcDJLLWg2S3pHaUx6V3pxZlY0?oc=5","date":"2023-03-30","type":"trial","source":"Nature","summary":"Results of a phase Ib study of SB-121, an investigational probiotic formulation, a randomized controlled trial in participants with autism spectrum disorder - Nature","headline":"Results of a phase Ib study of SB-121, an investigational probiotic formulation, a randomized controlled trial in partic","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxPdzFnTTVKV1NGYlFhYlN4dFZrLWx1bGhVUHJTWXBBdEpUVmJlSDFSYjBrNlRIUWg5WDhDMDZsZjVyYWg5cGxhcm9QeEFYVHlsX1A3VTU3UmxzQlpKWUd1b2VWWk1aTHlFYTZIZWxILXZiSUpiU3BZZkt1TnBrT3VjMmxZQWs0WlI5WVVQRDdSU0g?oc=5","date":"2023-03-09","type":"trial","source":"Yahoo Finance","summary":"Autistic Disorder Clinical Trial Pipeline Insights Featuring 25+ Companies | DelveInsight - Yahoo Finance","headline":"Autistic Disorder Clinical Trial Pipeline Insights Featuring 25+ Companies | DelveInsight","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}